APVNF yields 20000000.00% · PFE yields 6.13%● Live data
📍 APVNF pulled ahead of the other in Year 1
Combined, APVNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of APVNF + PFE for your $10,000?
ARISE Technologies Corporation, a solar technology company, develops and manufactures photovoltaic (PV) products. It operates in three divisions: PV Cell, PV Silicon, and PV Systems. The PV Cell division manufactures and supplies PV cells to PV module makers. The PV Silicon division produces silicon at 7N+ high-purity for PV applications. The PV Systems division provides solar PV energy systems for solar farms and building rooftop installation applications in North America. This division also offers solar systems design and engineering, solar energy efficiency analysis, and energy opportunity assessment services for solar energy projects to residential, industrial, commercial, and public sector clients in Ontario. The company was formerly known as CVCC Holdings Inc. and changed its name to ARISE Technologies Corporation in March 1997. ARISE Technologies Corporation was incorporated in 1993 and is based in Waterloo, Canada.
Full APVNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.